Log in

NASDAQ:SGRY - Surgery Partners Stock Price, Forecast & News

$14.51
-0.17 (-1.16 %)
(As of 12/16/2019 06:12 AM ET)
Today's Range
$14.41
Now: $14.51
$14.90
50-Day Range
$7.73
MA: $11.86
$15.29
52-Week Range
$5.38
Now: $14.51
$15.49
Volume231,555 shs
Average Volume304,107 shs
Market Capitalization$718.39 million
P/E RatioN/A
Dividend YieldN/A
Beta2.68
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. Read More…

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Book Value$22.48 per share

Profitability

Net Income$-205,710,000.00

Miscellaneous

Employees11,000
Market Cap$718.39 million
Next Earnings Date3/11/2020 (Estimated)
OptionableOptionable

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.


Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How will Surgery Partners' stock buyback program work?

Surgery Partners declared that its board has approved a share repurchase plan on Saturday, December 16th 2017, which permits the company to buyback $50,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board of directors believes its shares are undervalued.

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) announced its quarterly earnings data on Tuesday, November, 5th. The company reported ($0.28) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.34) by $0.06. The company earned $452 million during the quarter, compared to analyst estimates of $452.30 million. Surgery Partners had a negative return on equity of 5.32% and a negative net margin of 11.26%. Surgery Partners's revenue was up 1.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.19) earnings per share. View Surgery Partners' Earnings History.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Surgery Partners.

What price target have analysts set for SGRY?

2 analysts have issued 12 month price objectives for Surgery Partners' stock. Their forecasts range from $12.00 to $20.00. On average, they anticipate Surgery Partners' share price to reach $16.00 in the next twelve months. This suggests a possible upside of 10.3% from the stock's current price. View Analyst Price Targets for Surgery Partners.

What is the consensus analysts' recommendation for Surgery Partners?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.

Has Surgery Partners been receiving favorable news coverage?

News headlines about SGRY stock have been trending negative this week, InfoTrie reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Surgery Partners earned a news sentiment score of -2.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Surgery Partners.

Are investors shorting Surgery Partners?

Surgery Partners saw a increase in short interest in the month of November. As of November 15th, there was short interest totalling 7,100,000 shares, an increase of 6.9% from the October 31st total of 6,640,000 shares. Based on an average daily volume of 335,200 shares, the days-to-cover ratio is presently 21.2 days. Currently, 34.6% of the shares of the company are short sold. View Surgery Partners' Current Options Chain.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Mazor Robotics (MZOR), Allena Pharmaceuticals (ALNA), Athersys (ATHX), Rigel Pharmaceuticals (RIGL), Transocean (RIG), SM Energy (SM), Visa (V), American Airlines Group (AAL), Ardelyx (ARDX) and Corbus Pharmaceuticals (CRBP).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the folowing people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (1.32%), Pictet Asset Management Ltd. (1.30%), State Street Corp (0.91%), Squarepoint Ops LLC (0.19%), Alberta Investment Management Corp (0.09%) and Rhumbline Advisers (0.07%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View Institutional Ownership Trends for Surgery Partners.

Which institutional investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd.. View Insider Buying and Selling for Surgery Partners.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, State Street Corp, Squarepoint Ops LLC, Alberta Investment Management Corp, Barclays PLC and Rhumbline Advisers. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans and Teresa Deluca. View Insider Buying and Selling for Surgery Partners.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $14.51.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $718.39 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.

What is Surgery Partners' official website?

The official website for Surgery Partners is http://www.surgerypartners.com/.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]


MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  222 (Vote Outperform)
Underperform Votes:  292 (Vote Underperform)
Total Votes:  514
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Featured Article: What is net income?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel